MedPath

Identification and characterization of novel antibody biomarkers after spinal cord injury

Conditions
Spinal cord injury, BiomarkerRuggenmergschade, Biomerker
Registration Number
NL-OMON23009
Lead Sponsor
niversiteit Hasselt
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

All traumatic and pathological spinal cord injury patients can be included in this study (> 18 years both male and female).

Exclusion Criteria

The exclusion criteria of this study is the presence of pre-existing autoimmune disorders.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome of this study is to identify a panel of candidate biomarkers in spinal cord injury pathology.
Secondary Outcome Measures
NameTimeMethod
The secondary outcome of this study is to characterize the identified candidate biomarkers for their relevance in spinal cord injury pathology.
© Copyright 2025. All Rights Reserved by MedPath